Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies.

Richard B LiptonDavid W DodickDavid KudrowUwe ReuterNadia TenenbaumFeng ZhangGabriel Paiva da Silva LimaDenise E ChouDaniel D Mikol

Published in: Cephalalgia : an international journal of headache (2021)

Erenumab reduced cumulative monthly migraine pain in episodic migraine and chronic migraine patients and significantly reduced monthly average migraine pain in episodic migraine, demonstrating treatment benefit beyond reduction in migraine frequency.Clinical Trial Registration: ClinicalTrials.gov, NCT02456740; ClinicalTrials.gov, NCT02066415.

Keyphrases

chronic pain
clinical trial
pain management
neuropathic pain
end stage renal disease
double blind
ejection fraction
randomized controlled trial
peritoneal dialysis
replacement therapy
placebo controlled
smoking cessation